Eleven Biotherapeutics (EBIO) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS
Eleven Biotherapeutics (NASDAQ:EBIO) released its earnings data on Wednesday. The company reported ($0.51) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.47) by $0.04, Stock Ratings News reports.
Shares of Eleven Biotherapeutics (NASDAQ:EBIO) opened at 12.32 on Wednesday. Eleven Biotherapeutics has a 52-week low of $9.502 and a 52-week high of $19.333. The stock has a 50-day moving average of $12.07 and a 200-day moving average of $13.03. The company’s market cap is $189.6 million.
Eleven Biotherapeutics, Inc, is a United States-based company, which develops protein-based biotherapeutics.
Receive News & Ratings for Eleven Biotherapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eleven Biotherapeutics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.